[A first trial in the clinical study of bonnecor].
The brief data on the results of the clinical trials of a new antiarrhythmic drug bonnecor at intravenous administration performed in six clinical institutions of the country are presented. A high effectiveness and a good tolerance of the drug in VT, VE, ST, SE and WPW syndrome were revealed.
M I
MI
Mironova
V V
VV
Lyskovtsev
N V
NV
Kaverina
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003327:Coronary Disease / Q000188:drug therapy; D003984:Dibenzazepines / Q000627:therapeutic use*; D004361:Drug Tolerance; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy; D014586:USSR
D000889:Anti-Arrhythmia Agents; D003984:Dibenzazepines; C048166:tiracizine
Pervyĭ opyt klinicheskogo izucheniia bonnekora.